Johnson v. Glaxosmithkline, Inc., B199453
In a class action alleging deceptive advertising regarding the prescription drug Paxil, summary judgment for defendant is reversed where: 1) denial of class certification in a prior nation-wide class action regarding Paxil did not collaterally estop plaintiffs' attempt to certify a class limited to California members; and 2) denial of certification in another prior class action, of a class not limited to those who saw the allegedly deceptive Paxil advertisements, did not collaterally estop plaintiffs' claim, which does include allegation of injury resulting from seeing the advertisements.
- Decided 09/19/2008
- Published 09/19/2008
- California Court of Appeal
- For Appellant:
- Kabateck, Brown Kellner, Brian S. Kabateck, Richard L. Kellner and Alfredo Torrijos, Los Angeles; Khorrami Pollard & Abir, H. Scott Leviant, Santa Barbara, Shawn Khorrami and Matt C. Bailey, Los Angeles; Milstein Adelman & Kreger, Wayne S. Kreger, Santa Monica, and Paul D. Stevens for Plaintiff and Appellant.
- For Appellees:
- Drinker Biddle & Reath and William A. Hanssen, Los Angeles; King & Spalding, Todd P. Davis, Stephen B. Devereaux and Bradley W. Pratt for Defendant and Respondent.